相关实验视频
Updated: Mar 18, 2026

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
902
梅特福林的使用和食道状细胞癌的发展
Shao-Hua Xie1, Giola Santoni1, Helgi Birgisson2
1Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
JAMA network open
|March 16, 2026
概括
甲福明的使用与食道状细胞癌 (ESCC) 风险的显著降低有关. 这表明甲福明可能是ESCC的潜在预防或治疗剂.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 食道状细胞癌 (ESCC) 的预后不佳,需要采取预防策略.
- 以前的研究表明,甲福明使用与降低ESCC风险之间存在潜在联系,但证据仍然有限.
研究的目的:
- 调查甲福明使用与患ESCC的风险之间的关联.
- 在ESCC的背景下评估甲福明的潜在抗癌性质.
主要方法:
- 基于北欧国家 (1994-2023) 的数据进行了基于人口的病例控制研究.
- 13,050个ESCC病例与130,500个对照人群进行了比较,根据年龄,性别,日历年和国家进行了匹配.
- 条件后勤回归被用来计算赔率比率 (ORs),调整生活方式因素和药物使用.
主要成果:
- 使用甲胺与ESCC的几率降低了36% (OR,0.64;95% CI,0.59-0.69).
- 观察到一种剂量反应关系,较高的甲福明剂量显示出更大的风险降低 (OR,0.52;95% CI,0.44-0.61).
结论:
- 使用甲胺与ESCC的几率相对较低有关.
- 这些发现支持进一步调查甲胺作为高风险个体的预防措施和ESCC的潜在治疗剂.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
830
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
830
Barrett Esophagus-I: Introduction
1.2K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.2K
Barrett Esophagus-II: Clinical Manifestations and Management
1.4K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.4K
Esophageal Strictures-I: Introduction
1.1K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.1K
Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
63
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63

